Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 7:44 AM ET


Company Overview of Denali Therapeutics Inc.

Executive Profile

Steve Krognes

Chief Financial Officer, Denali Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships


Mr. Steve Krognes has been Chief Financial Officer of Denali Therapeutics Inc. since October 10 2015. Mr. Krognes served as Senior Vice President, Regional Head of Finance & IT and Chief Financial Officer of Pharma North America at Genentech, Inc. Mr. Krognes served as Executive Vice President and Chief Financial Officer of Genentech, Inc. He joined Roche in January 2004 as global head of Mergers and Acquisitions. He served as Head of Corporate Finance-Corporate Development ...

Corporate Headquarters

1700 Owens Street
San Francisco, California 94158

United States

Phone: --
Fax: --

Board Members Memberships



Harvard Business School
Bachelor's Degree
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Denali Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at